| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |